Hepatoprotective Effects of Chinese Medicine Herbs Decoction on Liver Cirrhosis in Rats by Mat-Rahim, N.A. et al.
Research Article
Hepatoprotective Effects of Chinese Medicine Herbs Decoction
on Liver Cirrhosis in Rats
Nor AziyahMat-Rahim,1,2 Tong-Hye Lim,3
Nur-Asyura Nor-Amdan,1 and Sazaly AbuBakar1
1Tropical Infectious Diseases Research and Education Center (TIDREC), Department of Medical Microbiology,
Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
2Virology Unit, Institute for Medical Research, Jalan Pahang, 50588 Kuala Lumpur, Malaysia
3Herbitec (M) Sdn Bhd, 11-2 Jalan Sri Hartamas 7, Taman Sri Hartamas, 50480 Kuala Lumpur, Malaysia
Correspondence should be addressed to Sazaly AbuBakar; sazaly@um.edu.my
Received 20 July 2016; Accepted 16 January 2017; Published 9 February 2017
Academic Editor: Luciana Dini
Copyright © 2017 Nor Aziyah Mat-Rahim et al.This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Hepatoprotective and curative activities of aqueous extract of decoction containing 10 Chinese medicinal herbs (HPE-XA-08)
were evaluated in Sprague–Dawley albino rats with liver damage induced by thioacetamide (TAA). These activities were assessed
by investigating the liver enzymes level and also histopathology investigation. Increases in alkaline phosphatase (ALP) and gamma-
glutamyl transferase (GGT) levels were observed in rats with cirrhotic liver. No significant alterations of the liver enzymes were
observed following treatment with HPE-XA-08. Histopathology examination of rats treated with HPE-XA-08 at 250mg/kg body
weight, however, exhibited moderate liver protective effects. Reduced extracellular matrix (ECM) proteins within the hepatocytes
were noted in comparison to the cirrhotic liver. The curative effects of HPE-XA-08 were observed with marked decrease in the
level of ALP (more than 3x) and level of GGT (more than 2x) in cirrhotic rat treated with 600mg/kg body weight HPE-XA-08 in
comparison to cirrhotic rat treated with just water diluent. Reversion of cirrhotic liver to normal liver condition in rats treated with
HPE-XA-08 was observed. Results from the present study suggest that HPE-XA-08 treatment assisted in the protection from liver
cirrhosis and improved the recovery of cirrhotic liver.
1. Introduction
Chronic liver disease is the ninth leading cause of mortality
inWestern and developing countries [1].The disease resulted
from chronic proinflammatory injuries, which could cause
progressive fibrosis causing the liver to scar and eventually
becomes cirrhotic. There are many factors that could lead to
chronic liver injury and among them are viral infections such
as hepatitis C infection, chronic alcoholism, and autoimmune
diseases and also due to drug or substance abuses. Five
percent of persons with liver cirrhosis could progress to
develop liver cancer [2].
To date, there is no specific treatment for liver cirrhosis.
Sufferers are treated to reduce the complications due to the
damaged liver from exacerbating. The treatments are often
expensive especially for those in developing countries where
there is high rate of liver cirrhosis in the population. Due to
these factors, treatment using ethnobotanical approach has
gained popularity as an alternative cost-effective approach
[1, 3]. Among the ethnobotanical approaches, the Chinese
herbal medicine has been widely applied. It serves as alterna-
tive complementary medicine, probably due to the presence
of complete pharmacopeia of the herbs established over
more than 5000 years of traditional use. Currently, in many
healthcare facilities in China, traditional Chinese medicine
is being applied in complement to Western medicine [4].
Typical in most traditional Chinese medicines, the formu-
lation consists of multiple herbs concoction. It has been
suggested that the combination of herbs with the various
combinations of natural ingredients may produce synergistic
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effects and neutralize potential side effects of an individual
herb constituent, hence augmenting the effectiveness of a
treatment [5–7].
The present study aims to evaluate the preventive and
potential curative effects of a decoction containing 10Chinese
medicinal herbs,HPE-XA-08, inwhich a number of the herbs
have been reported to be useful in supporting liver functions
and help to ameliorate liver fibrosis/cancer [8–11].
2. Materials and Methods
2.1. Plant Extracts. Aqueous extract of HPE-XA-08 con-
taining mixture of 10 Chinese medicinal herbs, comprising
fructus Gardenia jasminoides Ellis, Var. radicans (Thunb.)
Makino, Artemisia scoparia Waldst. Et Kit, radix Rheum
tanguticum Maxim. Ex Balf, radix Scutellaria baicalensis
Georgi, fructus Ligustrum lucidum Ait, cortex Phellodendron
amurense Rupr., Poria cocoa (Schw.) Wolf, radix Bupleurum
B. scorzoneraefolium Willd, and flos Chrysanthemum mori-
folium Ramat and herbs Tarxacum mongolicum Hand, Mazz
were prepared according to propriety extraction method of
Herbitec (M) Sdn. Bhd. The aqueous extract was filtered to
remove all the coarse residues, sterile filtered, and kept at
−20∘C until being needed for the study.
2.2. Animals. Male Sprague–Dawley (SD) rats aged between
7 and 10 weeks were kept in the University Malaya animal
breeding house. Animals were fed with standard pellet diet
and water ad libitum at 20–25∘C. All animal handlings
and protocols were in accordance with the institutional
guidelines for laboratory animals (Ethic Reference Number
PM/27/08/2011/MAA(R)).
2.3. Evaluation for Prevention and Treatment of TAA-Induced
Liver Cirrhosis by HPE-XA-08. Preventive effects for liver
cirrhosis conferred by HPE-XA-08 were evaluated using the
SD rats. Rats were assigned to 4 groups, namely, Group 1P:
control group 1 (normal saline + H2O), Group 2P: control
group 2 (normal saline + HPE-XA-08), Group 3P: TAA
control group (TAA+ H2O), and Group 4P: treated group
(TAA + HPE-XA-08 treatment; pretreatment with HPE-XA-
08, 300mg/kg). Rats from Groups 1P and 2P were injected
intraperitoneally (ip) with normal saline while Groups 3P
and 4P were injected with thioacetamide (TAA) at a dose
of 200mg/kg twice weekly for 12 weeks. HPE-XA-08 was
administered orally at 300mg/kg via a stomach tube to rats
in Groups 2P and 4P daily, up to 12 weeks, while Group
1P and Group 3P were fed with distilled water. For the
evaluation of HPE-XA-08 treatment on TAA-induced liver
cirrhosis, 3 rat groups were assigned, namely, Group 1T:
normal control group, Group 2T: cirrhosis control group, and
Group 3T: treatment group (posttreatment withHPE-XA-08,
600mg/kg). Liver cirrhosis was induced in rats of Groups 2T
and 3T by inoculating TAA at 200mg/kg intraperitoneally,
twice weekly, for 12 weeks. Rats of Group 1T that served as
normal control were inoculated with normal saline. After 12
weeks, the TAAwas stopped and the rats fromGroup 3Twere
treated with 600mg/kgHPE-XA-08 as described above while
rats of Groups 1T and 2T were treated with distilled water
of the equivalent volume. Blood was collected from each rat
before and after the treatment. The treatment was performed
for 30 days.
2.4. Hepatic Biochemical Evaluation. Blood of each rat was
collected via tail vein before the treatment and at the end of
the treatment regime. The blood was collected in tube con-
taining EDTA and analyzed for the liver function enzymes
serum alanine transaminase (ALT), aspartate transaminase
(AST), alkaline phosphatase (ALP), and gamma-glutamyl
transferase (GGT) in the Clinical Diagnostic Laboratory
(CDL) at University Malaya Medical Centre (UMMC).
Immediately after the final blood collection, the rats were
euthanized and the organs were harvested for histological
investigation.
2.5. Histopathological Analysis. Liver samples harvested from
the rats were washed with the normal saline and immediately
fixed in 10% buffered neutral formalin for 48 hours. Samples
were then embedded in paraffin wax. Sections of 5-micron
thickness were prepared, processed in alcohol-xylene series,
and stained with alum-haematoxylin and eosin, prior to
histopathological examination.
2.6. Statistical Analysis. Results were presented as mean ±
SEM of six animals in each group. The data were subjected
to one-way ANOVA followed by Bonferroni’s posttest. 𝑝 <
0.05 was considered statistically significant. Analysis was
performed using GraphPad Prism version 4.00 for Windows
(GraphPad Software, USA).
3. Results
3.1. Prevention of TAA-Induced Liver Cirrhosis. The effects of
HPE-XA-08 on serumALT,AST,ALP, andGGTandbilirubin
activities in rats from all treatment groups were shown in
Table 1. It is observed that the serum ALT and AST activities
in all rat groups, Groups 1P, 2P, 3P, and 4P, did not show
any significant differences following the preventive treatment
regime. It was noted that the serum ALT activity in rat group
treated with HPE-XA-08 showed lower ALT activity with
value of 76.0 ± 4.416 IU/L (Group 2P) and 69.40 ± 7.756 IU/L
(Group 4P) in comparison to 80.0 ± 4.175 IU/L (Group 1P)
and 88.5 ± 12.75 IU/L (Group 3P). For serum AST level,
the TAA control group (Group 3P) showed the lowest level
with value of 215.0 ± 13.64 IU/L, followed by Groups 4P, 2P,
and 1P with values of 222.4 ± 5.715 IU/L, 223.3 ± 11.16 IU/L,
and 237.3 ± 12.84 IU/L, respectively. Serum ALP level in rat
groups injected with TAA (Groups 3P and 4P) were higher
in comparison to those injected with normal saline only
(Groups 1P and 2P). The highest level of ALP was observed
in Group 3P with value of 375.0 ± 10.41 IU/L. The ALP level
in rat group injected with TAA and treated with HPE-XA-
08 (Group 4P) was observed to be lower than those treated
with water (Group 3P) with value of 277 ± 4.722 IU/L. The
serum GGT levels in rat groups injected with TAA (Groups
3P and 4P) were significantly higher in comparison to the
control groups (Groups 1P and 2P). Serum GGT levels in
TAA control group (Group 3P) were the highest with value
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Table 1: Effect of HPE-XA-08 on blood biochemicals related to liver damage (ALT, AST, ALP, andGGT) for observation of protective activity.
Group ALT (IU/L) AST (IU/L) ALP (IU/L) GGT (IU/L)
Normal saline + H2O (1P) 80.00 ± 4.175 237.3 ± 12.84 173.6 ± 7.807 2.286 ± 0.4206
Normal saline + HPE-XA-08 (2P)# 76.00 ± 4.416 223.3 ± 11.16 170.3 ± 23.68 3.750 ± 0.4787
TAA + H2O (3P) 88.50 ± 12.75 215.0 ± 13.64 375.0 ± 10.41
∗ 37.50 ± 1.857∗
TAA + HPE-XA-08 (4P)+ 69.40 ± 7.756 222.4 ± 5.715 277.0 ± 4.722 30.80 ± 3.980
∗Levels of enzymes between 1P and 3P were compared to show the effects of TAA on the level of liver enzymes; ∗ indicates 𝑝 < 0.05.
#Levels of enzymes between 1P and 2P were compared to show the effects of HPE-XA-08 on the level of liver enzymes but did not show statistically significant
value (𝑝 > 0.05).
+Levels of enzymes between 3P and 4P were compared to show the effects of HPE-XA-08 on preventing TAA-induced liver cirrhosis but did not show
statistically significant value (𝑝 > 0.05).
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Figure 1: Macroscopic and histologic analysis of liver harvested from rats. Liver samples were harvested from rats inoculated with normal
saline and treated with water (a), inoculated with normal saline and treated with HPE-XA-08 (c), inoculated with TAA (200mg/kg) twice
weekly and treated with water (e), and inoculated with TAA and treated with HPE-XA-08 (g).The sections from harvested liver were stained
with hematoxylin-eosin, respectively (b, d, f, h).
of 37.50 ± 1.857 IU/Lmmol/L.The rat group 4P (TAA +HPE-
XA-08 treatment) showed lower GGT level when compared
to the TAA control group (Group 3P) with value of 30.80 ±
3.980 IU/Lmmol/L.
Histological examination of liver section of rats from the
control groups (Groups 1P and 2P) showed that the liver was
dark red in color, with smooth homogenous surface texture
(Figures 1(a) and 1(c)). The liver of rats from Group 3P was
observed to be slightly brownish in color. The surface was
rough, irregular with highly nodulated morphology (Fig-
ure 1(e)). In the rat group of TAA + HPE-XA-08 treatment
(Group 4P), although the color of the liver was noted as dark
brown, the surface of the liver was smoother and the nodules
were not as distinct as the liver of rat group 3P (Figure 1(g)).
The liver section of rats from control groups (Groups 1P
and 2P) showed a homogenous distribution of hepatic cells
devoid of extracellular matrix protein (ECM; Figures 1(b)
and 1(d)). The liver section of TAA-treated control group
(Group 3P) exhibited marked presence of ECM extending
through the hepatic lobules and displayed as large fibrous
septa (Figure 1(f)). However, no special histological staining
was performed to determine the component of the septa.
In the liver section of the TAA + HPE-XA-08 treatment
group (Group 4P), the presence of ECM was almost not
detected.Thefibrous septawere not present as those observed
in Figure 1(f), although trace of injury can still be observed
(Figure 1(h)).
3.2. Treatment of TAA-Induced Liver Cirrhosis. The possi-
bility for HPE-XA-08 to reverse liver cirrhosis in rats was
also evaluated. All rats were inoculated with TAA to induce
liver cirrhosis, except for rat group 1T which was inoculated
with normal saline to serve as control group (normal rat).
Following 12 weeks of induction of liver cirrhosis with TAA,
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Figure 2:Macroscopic analysis of cirrhotic liver following treatment regime. Liver cirrhosis was induced by TAA for 12 weeks. After 12 weeks,
the TAA was discontinued and rats were treated with either water (b) or HPE-XA-08 (c). Normal rat was included as negative control and
treated with water (a).
the rats were either treated with distilled water (Group 2T)
or with 600mg/kg HPE-XA-08 for 30 days (Group 3T). The
hepatic biochemical activities in normal and cirrhotic rats
were evaluated before and after the treatment regime. The
hepatic enzyme levels of ALT, AST, ALP, and GGT were
measured (Table 2). It was noted that the AST, ALP, and
GGT levels decreased after the 30-day treatment in all rat
groups. The ALT level, however, was noted to increase in
the cirrhotic rat groups (Groups 2T and 3T) following the
30-day treatment with increment from 62 ± 0.636 IU/L to
75 ± 0.577 IU/L in Group 2T and 63 ± 1.202 IU/L to 69
± 0.441 IU/L in Group 3T. Withdrawal of TAA helped to
significantly reduce the level of ALP and GGT in Group 2T
although the rats were treated with just water. In rats treated
with HPE-XA-08 (Group 3T), further decrease of ALP and
GGT levels with reduction from 368 ± 0.882 IU/L to 102 ±
2.333 IU/L and 39 ± 0.296 IU/L to 15 ± 0.441 IU/L for ALP
and GGT, respectively, was observed. The AST level was
reduced significantly following treatment with HPE-XA-08
with reduction from 179 ± 0.882 IU/L to 158 ± 0.882 IU/L.
Unlike those treated with HPE-XA-08, the AST level in the
cirrhotic rat treated with water was 180 ± 1.155 IU/L and
175 ± 0.667 IU/L before and after treatment, respectively.
Macroscopic observation of the liver from the normal control
rat (Group 1T) showed the liver to be dark red in color with
smooth homogenous surface (Figure 2(a)). In the cirrhotic
control group treated with water (Group 2T), although the
TAA has been discontinued, the liver was slightly brownish
with macronodular structure and irregular nonhomogenous
surface (Figure 2(b)). For the cirrhotic rats treated with HPE-
XA-08, the color of the liver was more reddish compared
to the group treated with only water (Figure 2(c)). The liver
surface showed no obvious nodular structure and the surface
of the liver was comparable to the normal liver.
4. Discussion
Hepatic cirrhosis, a consequence of hepatic fibrosis, is
characterized by exaggerated production of extracellular
matrix properties (ECM) [12]. Hepatic cirrhosis induced by
thioacetamide (TAA) lead to steatosis, which is associated
with the aggravation of lipid peroxidation and depletion of
antioxidant status [13].
In the present study, liver damage is manifested by
increases in serum ALP, GGT, and bilirubin levels. TAA-
induced liver cirrhosis, however, was usually not character-
ized by high serumALT and AST, unlike those intoxicated by
CCl4 and paracetamol [14, 15]. Further, it has been reported
that the severity of liver injury does not correlate with the
level of liver enzyme elevation [16]. From our observation
on the preventive effects of HPE-XA-08 on liver cirrhosis,
although the differences between the level of liver enzymes
in those untreated and those treated with HPE-XA-08 were
not significant, except for level of GGT, the macroscopic and
histologic examinations supported that treatment with HPE-
XA-08 protected the liver against severe damage. Based on
our findings, ALP and GGT could be employed as indica-
tor in evaluating liver damage induced by TAA; however,
the enzyme levels may not corroborate with the physical
condition of the liver. The histological observation of the
liver of rats given TAA was consistent with that reported
by Bruck et al. [12], where increase in ECM was noted. In
this study, however, we did not determine the mechanisms of
action of the herbal concoction (HPE-XA-08) in providing
the protective effects on the liver against induced damage.
We postulated that the HPE-XA-08 decoction may affect the
collagen content in the liver by either increasing the collagen
synthesis, or reducing the collagen degradation, which was
evidenced by the resolution of the fibrotic lesion and ECM in
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the liver of HPE-XA-08-treated rat observedmacroscopically
and histologically. The liver harvested from cirrhotic rat
treated with HPE-XA-08 showed accelerated resolution of
existing fibrosis. The morphology of the liver has reverted
to almost comparable to the normal liver (Figure 2(c)). This
finding was consistent with reports by Chen et al. [17] and
Park et al. [18] that demonstrated that 2 out of 10 components
within HPE-XA-08 andGardenia jasminoides and Scutellaria
baicalensis play a role in attenuation of collagen accumulation
and apoptosis of hepatic stellate cells (HSCs), respectively,
which help in resolution of liver fibrosis. Other than that, the
resolution of liver damage may also be assisted by extract of
Ligustrum lucidum which was reported to induce apoptosis
and cell senescence in human hepatocellular carcinoma [19].
Liver fibrosis and cirrhosis were earlier thought of as irre-
versible processes. However, recent clinical and experimental
evidences suggest that the process can be reversed [2, 20].
To assess the potential curative effects of HPE-XA-08 on
liver cirrhosis, the hepatotoxic TAA was removed during the
treatment process. We noted that although TAA has been
withdrawn for 30 days, the liver nodulation could still be
observed (Figure 2(b)); however, the liver condition was not
as nodulated as observed in the liverwith the presence of TAA
(Figure 1(e)) suggesting possible arrest of progressive liver
damage. Previous report showed that TAA-induced steatosis
was due to accumulation of lipids within the hepatocytes [21].
Our observation in the rats’ cirrhotic liver was consistent
with this report (Figure 2(b)), where lipid nodules could
be observed in the cirrhotic liver of rats treated with water
(H2O). Amelioration of hyperlipidemic liver observed in
our study could be contributed by constituents present in
Chrysanthemum morifolium and Artemisia scoparia (within
HPE-XA-08 decoction), which has been described to atten-
uate high-fat milk-induced fatty liver and reduce the liver
lipid accumulation, respectively [22, 23]. In the assessment
of liver enzyme, the level obtained before the treatment was
used as a baseline to be compared to the enzyme level after
the treatment. It was noted that the levels of liver enzyme in
normal rat decreased after 30 days of treatment with water.
This could be related to the age of the rat, since age does affect
the liver enzymes [24], which indicated that observation
of liver enzyme level alone was insufficient in evaluating
hepatoprotective effects conferred by any herbal supplement
and needed to be complemented with biopsy or histology.
Most of the previous studies on the antihepatofibrotic
were performed on single plant/herb extract. In this study,
the hepatocellular injury and fibrosis in rats were treated
orally with decoction consisting of 10 medicinal Chinese
herbs, named HPE-XA-08. Other than the 5 plants/herbs
within HPE-XA-08 that have been mentioned above, the
remaining 4 plants/herbs in the decoction, Phellodendron
amurense, Poria cocoa, Bupleurum B. scorzoneraefolium, and
Tarxacum mongolicum, scientifically were reported to exert
anticarcinogenic and antitumor properties [25–28]. Based on
our findings, we conclude that the decoction consisting of
the 10 medicinal Chinese herbs, named HPE-XA-08, pos-
sesses potential hepatoprotective and curative effects against
damaged liver. Further investigations, however, are needed
to identify the hepatoprotective mechanisms conferred by
this aqueous herbal preparation.The present finding provides
scientific evidence that the mixture of these 10 Chinese tra-
ditional herbs preparation possessed ethnomedicinal prop-
erties in maintaining liver function and could be developed
further as ethnomedicine for liver injuries.
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